Analysis of biofluids for biomarker research

Proteomics - Clinical Applications

Volumn 2, Issue 10-11, 2008, Pages 1403-1412

  Xu, Xia ^a   Veenstra, Timothy D ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

2 D DIGE; 2 D PAGE; Biomarkers; Mass spectrometry; Quantitative proteomics

Indexed keywords

ALPHA 1 ACID GLYCOPROTEIN 1; ALPHA 1 ACID GLYCOPROTEIN 2; ALPHA 2HS GLYCOPROTEIN; AMYLOID A PROTEIN; APOLIPOPROTEIN A4; APOLIPOPROTEIN C2; APOLIPOPROTEIN D; APOLIPOPROTEIN E; BIOLOGICAL MARKER; CERULOPLASMIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; GLYCOPROTEIN; INTER ALPHA TRYPSIN INHIBITOR; INTER ALPHA TRYPSIN INHIBITOR CHAIN H14; PREALBUMIN; PREGNANCY ASSOCIATED PROTEIN; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING PROTEIN; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; AMINO ACID SEQUENCE; ANTIBODY AFFINITY; BODY FLUID; CHROMATOFOCUSING; DIAGNOSTIC ACCURACY; DOWN SYNDROME; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; INTERSTITIAL CYSTITIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN TARGETING; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINALYSIS;

EUKARYOTA; PROKARYOTA;

EID: 67449146319     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780173     Document Type: Review

References (34)

1. Megason, S. G., Fraser, S. E., Imaging in systems biology. Cell 2007, 130, 784-795.
2. Srinivasan, B. S., Shah, N. H., Flannick, J. A., Abeliuk, E. et al., Current progress in network research: Toward reference networks for key model organisms. Brief. Bioinform. 2007, 8, 318-332.
3. Ivakhno, S., From functional genomics to systems biology. FEBS J. 2007, 274, 2439-2448.
4. Hedge, P. S., White, I. R., Debouck, C., Interplay of transcriptomics and proteomics. Curr. Opin. Biotechnol. 2003, 14, 647-651.
5. Veenstra, T. D., Global and targeted quantitative proteomics for biomarker discovery. J. Chromatogr., B Analyt. Technol. Biomed. Life Sci. 2007, 847, 3-11.
6. Zhou, M., Veenstra, T. D., Proteomic analysis of protein complexes. Proteomics 2007, 7, 2688-2697.
7. Guerrera, I. C., Kleiner, O., Application of mass spectrometry in proteomics. Biosci. Rep. 2005, 25, 71-93.
8. Yan, W., Chen, S. S., Mass spectrometry-based quantitative proteomic profiling. Brief. Funct. Genomic. Proteomic. 2005, 4, 27-38.
9. Johann, D. J., Jr., Blonder, J., Biomarker discovery: Tissue versus fluids versus both. Expert Rev. Mol. Diagn. 2007, 7, 473-475.
10. Zhang, H., Liu, A. Y., Loriaux, P., Wollscheid, B. et al., Mass spectrometric detection of tissue proteins in plasma. Mol. Cell. Proteomics 2007, 6, 64-71.
11. Faca, V., Pitteri, S. J., Newcomb, L., Glukhova, V. et al., Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J. Proteome Res. 2007, 6, 3558-3565.
12. Kasthuri, R. S., Verneris, M. R., Ibrahim, H. N., Jilma, B., Nelsestuen, G. L., Studying multiple protein profiles over time to assess biomarker validity. Expert Rev. Proteomics 2006, 3, 455-464.
13. Xu, X., Roman, J. M., Issaq, H. J., Keefer, L. K. et al., Quantitative-measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal. Chem. 2007, 15, 7813-7821.
14. Keay, S. K., Szekely, Z., Conrads, T. P., Veenstra, T. D. et al., An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related siaolglycopeptide. Proc. Natl. Acad. Sci. USA 2004, 101, 11803-11808.
15. Nagalla, S. R., Canick, J. A., Jacob, T., Schneider, K. A. et al., Proteomic analysis of maternal serum in down syndrome: Identification of novel protein biomarkers. J. Proteome Res. 2007, 6, 1245-1257.
16. Zolotarjova, N., Martosella, J., Nicol, G., Bailey, J. et al., Differences among techniques for high-abundant protein depletion. Proteomics 2005, 5, 3304-3313.
17. Bjorhall, K., Miliotis, T., Davidsson, P., Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 2005, 5, 307-317.
18. Baussant, T., Bougueleret, L., Johnson, A., Rogers, J. et al., Effective depletion of albumin using a new peptide-based affinity medium. Proteomics 2005, 5, 973-977.
19. Sahab, Z. J., Iczkowski, K. A., Sang, Q. X., Anion exchange fractionation of serum proteins versus albumin depletion. Anal. Biochem. 2007, 368, 24-32.
20. Petric, T. C., Brne, P., Gabor, B., Govednik, L. et al., Anionexchange chromatography using short monolithic columns as a complementary technique for human serum albumin depletion prior to human plasma proteome analysis. J. Pharm. Biomed. Anal. 2007, 43, 243-249.
21. Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J. et al., Characterization of the low molecular weight human serum proteome. Mol. Cell. Proteomics 2003, 2, 1096-1103.
22. Darde, V. M., Barderas, M. G., Vivanco, F., Depletion of high-abundance proteins in plasma by immunoaffinity substraction for two-dimensional gel electrophoresis analysis. Methods Mol. Biol. 2007, 357, 351.
23. Gong, Y., Li, X., Yang, B., Ying, W. et al., Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J. Proteome Res. 2006, 5, 1379.
24. Elrick, M. M., Walgren, J. L., Mitchell, M. D., Thompson, D. C., Proteomics: Recent applications and new technologies. Basic Clin. Pharmacol. Toxicol. 2006, 98, 432-441.
25. Sheta, E. A., Appel, S. H., Goldknopf, I. L., 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases. Expert Rev. Proteomics 2006, 3, 45-62.
26. Pawlik, T. M., Kuerer, H. M., The evolving role of proteomics in the early detection of breast cancer. Int. J. Fertil. Womens Med. 2005, 50, 212-216.
27. Maurya, P., Meleady, P., Dowling, P., Clynes, M., Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res. 2007, 27, 1247-1255.
28. Unlü, M., Morgan, M. E., Minden, J. S., Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
29. Link, A. J., Eng, J., Schieltz, D. M., Carmack, E. et al., Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 17, 676-682.
30. Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T. et al., The human plasma proteome: A nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 2004, 3, 311-326.
31. Shen, Y., Kim, J., Strittmatter, E. F., Jacobs, J. M. et al., Characterization of the human blood plasma proteome. Proteomics 2005, 5, 4034-4045.
32. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M.W., Gygi, S. P., Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 6940-6945.
33. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
34. Keshishian, H., Addona, T., Burgess, M., Kuhn, E., Carr, S. A., Quantitative, multiplexed assays for low abundance proteins in plasma by targeted MS and stable isotope dilution. Mol. Cell. Proteomics 2007, 6, 2212-2219.